Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.
Multiple locations, including HuntsvilleThis study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-61393215 for depression.
Multiple locations, including Garden GroveThis study is completed in the United States. It is testing JZP150 for PTSD.
Multiple locations, including PhoenixThis study was terminated in the United States. It focuses on Bipolarity.
In New HavenThis study is completed in the United States. It is testing ketamine for treatment-resistant depression.
Multiple locations, including Birmingham
This study is completed in the United States. It is testing label Compliance for ADHD.
In TitusvilleThis study is completed. It is testing Long-acting Injectable Risperidone for schizophrenia.
Location not clearly listedThis study is completed in Taiwan. It is testing Lurasidone HCl for schizophrenia.
In TaipeiThis study was terminated in the United States, in Mexico, in Russia, .... It is testing LY2140023 for schizophrenia.
Multiple locations, including WichitaThis study is completed in the United States, in Israel, in Italy, .... It is testing LY2140023 for schizophrenia.
Multiple locations, including Garden GroveThis study is completed in Singapore. It is testing LY2979165 for Bipolarity.
In SingaporeThis study has an unknown status in China. It is testing mianserin for depression.
In ShanghaiHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.